论文部分内容阅读
目的分析血清CA125在子宫内膜异位症诊断中的价值。方法回顾性分析102例卵巢子宫内膜异位症的患者,对患者的基本资料、CA125水平,卵巢囊肿等方面进行研究分析。结果子宫内膜异位症I期、Ⅱ期患者的平均CA125基本正常,Ⅲ期、Ⅳ期患者的平均CA125水平显著提高;四组患者的阳性率分别为33.33%(I期),54.17%(Ⅱ期),75.00%(Ⅲ期),90.63%(Ⅳ期),且组间比较差异有统计学意义(P<0.05)。结论 CA125在诊断卵巢子宫内膜异位症方面具有一定的优势,可以作为一种非创伤性辅助手段应用于临床。
Objective To analyze the value of serum CA125 in the diagnosis of endometriosis. Methods A retrospective analysis of 102 cases of ovarian endometriosis patients, the basic data of patients, CA125 levels, ovarian cysts and other aspects of research and analysis. Results The average level of CA125 in stage I and II patients with endometriosis was basically normal, and the average CA125 levels in stage III and IV patients were significantly increased. The positive rates of the three groups were 33.33% (stage I), 54.17% (stage I) Ⅱ), 75.00% (Ⅲ) and 90.63% (Ⅳ), respectively. There was significant difference between the two groups (P <0.05). Conclusion CA125 has some advantages in the diagnosis of ovarian endometriosis and can be used as a non-invasive adjunct in clinical practice.